Paper41780554
Preclinical pharmacology and toxicology study of an AAV8-tATP7B vector for Wilson's disease.
Wang Z and 10 others. Clin Mol Hepatol, 2026. Cited by 0 papers, by iCite.
Cite this record
ConductScience Library. Preclinical pharmacology and toxicology study of an AAV8-tATP7B vector for Wilson's disease. Papers, record 41780554. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/41780554
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Preclinical pharmacology and toxicology study of an AAV8-tATP7B vector for Wilson's disease.
- PubMed
Topics21
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Hepatolenticular Degeneration | Major topic |
| Genetic Vectors | Major topic |
| Dependovirus | Major topic |
| Adenosine Triphosphatases | Major topic |
| Cation Transport Proteins | Major topic |
| Animals | |
| Humans | |
| Copper-Transporting ATPases | |
| Hep G2 Cells | |
| Mice | |
| Genetic Therapy | |
| Rats | |
| Macaca fascicularis | |
| Copper | |
| Rats, Sprague-Dawley | |
| Gene Therapy Agents | |
| Liver | |
| Male | |
| Mice, Knockout | |
| Disease Models, Animal | |
| Female |
Source PubMed
Grants3
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2023ZD0508700 | Noncommunicable Chronic Diseases-National Science and Technology Major Project | PubMed | ||
| 2021YFC2700802 | National Key Research and Development Program of China | PubMed | ||
| XKPF2024B401 | Shanghai Jiao Tong University School of Medicine | PubMed |
Source PubMed
References38
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 37707949 | Genome editing without nucleases confers proliferative advantage to edited hepatocytes and corrects Wilson disease. | JCI Insight | 2023 | https://conductscience.org/library/papers/37707949 | PubMed |
| 2 | 31668086 | Long-Term Correction of Copper Metabolism in Wilson's Disease Mice with AAV8 Vector Delivering Truncated ATP7B. | Hum Gene Ther | 2019 | https://conductscience.org/library/papers/31668086 | PubMed |
| 3 | 30879562 | Liver Transplantation for Wilson's Disease in Non-adult Patients: A Systematic Review. | Transplant Proc | 2019 | https://conductscience.org/library/papers/30879562 | PubMed |
| 4 | 35994385 | Immune Responses and Immunosuppressive Strategies for Adeno-Associated Virus-Based Gene Therapy for Treatment of Central Nervous System Disorders: Current Knowledge and Approaches. | Hum Gene Ther | 2022 | https://conductscience.org/library/papers/35994385 | PubMed |
| 5 | 33987430 | Therapeutic strategies in Wilson disease: pathophysiology and mode of action. | Ann Transl Med | 2021 | https://conductscience.org/library/papers/33987430 | PubMed |
| 6 | 39056796 | Navigating the CRISPR/Cas Landscape for Enhanced Diagnosis and Treatment of Wilson's Disease. | Cells | 2024 | https://conductscience.org/library/papers/39056796 | PubMed |
| 7 | 37415533 | Efficient removal of antibodies to adeno-associated viruses by immunoadsorption. | J Clin Apher | 2023 | https://conductscience.org/library/papers/37415533 | PubMed |
| 8 | 37890721 | Adeno-associated viruses for gene therapy - clinical implications and liver-related complications, a guide for hepatologists. | J Hepatol | 2024 | https://conductscience.org/library/papers/37890721 | PubMed |
| 9 | 16014954 | Packaging capacity of adeno-associated virus serotypes: impact of larger genomes on infectivity and postentry steps. | J Virol | 2005 | https://conductscience.org/library/papers/16014954 | PubMed |
| 10 | 16803697 | Lentiviral gene transfer ameliorates disease progression in Long-Evans cinnamon rats: an animal model for Wilson disease. | Scand J Gastroenterol | 2006 | https://conductscience.org/library/papers/16803697 | PubMed |
| 11 | 32483358 | IgG-cleaving endopeptidase enables in vivo gene therapy in the presence of anti-AAV neutralizing antibodies. | Nat Med | 2020 | https://conductscience.org/library/papers/32483358 | PubMed |
| 12 | 21629225 | A 10 patient case report on the impact of plasmapheresis upon neutralizing factors against adeno-associated virus (AAV) types 1, 2, 6, and 8. | Mol Ther | 2011 | https://conductscience.org/library/papers/21629225 | PubMed |
| 13 | 40104154 | Evaluation of efficacy and safety of AAV8-ΔC4ATP7B gene therapy in a mutant mouse model of Wilson's disease. | Mol Ther Methods Clin Dev | 2025 | https://conductscience.org/library/papers/40104154 | PubMed |
| 14 | 16791614 | Regional distribution of mutations of the ATP7B gene in patients with Wilson disease: impact on genetic testing. | Hum Genet | 2006 | https://conductscience.org/library/papers/16791614 | PubMed |
| 15 | 30232804 | Age and Sex but Not ATP7B Genotype Effectively Influence the Clinical Phenotype of Wilson Disease. | Hepatology | 2019 | https://conductscience.org/library/papers/30232804 | PubMed |
| 16 | 28271598 | Dynamics of the metal binding domains and regulation of the human copper transporters ATP7B and ATP7A. | IUBMB Life | 2017 | https://conductscience.org/library/papers/28271598 | PubMed |
| 17 | 35586338 | Wilson Disease: Update on Pathophysiology and Treatment. | Front Cell Dev Biol | 2022 | https://conductscience.org/library/papers/35586338 | PubMed |
| 18 | 30706949 | Liver Expression of a MiniATP7B Gene Results in Long-Term Restoration of Copper Homeostasis in a Wilson Disease Model in Mice. | Hepatology | 2019 | https://conductscience.org/library/papers/30706949 | PubMed |
| 19 | 38024395 | Readministration of high-dose adeno-associated virus gene therapy vectors enabled by ImmTOR nanoparticles combined with B cell-targeted agents. | PNAS Nexus | 2023 | https://conductscience.org/library/papers/38024395 | PubMed |
| 20 | 33815421 | Anti-AAV Antibodies in AAV Gene Therapy: Current Challenges and Possible Solutions. | Front Immunol | 2021 | https://conductscience.org/library/papers/33815421 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| ATP7B | 540 | PubTator's text mining | https://conductscience.org/library/genes/540 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Cited by
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/41780554
GET https://conductscience.org/api/papers/v1/41780554/references?page=2